A detailed history of Highlander Capital Management, LLC transactions in Viatris Inc stock. As of the latest transaction made, Highlander Capital Management, LLC holds 36,846 shares of VTRS stock, worth $461,311. This represents 0.18% of its overall portfolio holdings.

Number of Shares
36,846
Previous 38,158 3.44%
Holding current value
$461,311
Previous $413,000 6.3%
% of portfolio
0.18%
Previous 0.18%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 20, 2024

SELL
$11.27 - $13.53 $14,786 - $17,751
-1,312 Reduced 3.44%
36,846 $439,000
Q4 2023

Jan 24, 2024

SELL
$8.77 - $10.85 $24,696 - $30,553
-2,816 Reduced 6.87%
38,158 $413,000
Q3 2023

Nov 13, 2023

BUY
$9.59 - $11.35 $51,306 - $60,722
5,350 Added 15.02%
40,974 $404,000
Q2 2023

Aug 14, 2023

SELL
$9.02 - $10.29 $10,138 - $11,565
-1,124 Reduced 3.06%
35,624 $355,000
Q1 2023

May 15, 2023

SELL
$9.2 - $12.26 $23,165 - $30,870
-2,518 Reduced 6.41%
36,748 $353,000
Q4 2022

Feb 15, 2023

SELL
$8.72 - $11.56 $21,956 - $29,108
-2,518 Reduced 6.03%
39,266 $437,000
Q2 2022

Aug 15, 2022

SELL
$9.95 - $12.27 $93,032 - $114,724
-9,350 Reduced 18.29%
41,784 $437,000
Q4 2021

Feb 14, 2022

SELL
$12.09 - $14.68 $30,225 - $36,700
-2,500 Reduced 4.66%
51,134 $692,000
Q3 2021

Nov 15, 2021

SELL
$13.25 - $15.13 $26,500 - $30,260
-2,000 Reduced 3.59%
53,634 $727,000
Q2 2021

Aug 10, 2021

SELL
$12.97 - $16.15 $7,457 - $9,286
-575 Reduced 1.02%
55,634 $795,000
Q1 2021

May 14, 2021

BUY
$13.59 - $18.54 $472,225 - $644,227
34,748 Added 161.91%
56,209 $785,000
Q4 2020

Feb 12, 2021

BUY
$14.3 - $18.74 $306,892 - $402,179
21,461 New
21,461 $402,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Highlander Capital Management, LLC Portfolio

Follow Highlander Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highlander Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highlander Capital Management, LLC with notifications on news.